Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Gross Margin (2020 - 2025)

NeuroPace has reported Gross Margin over the past 6 years, most recently at 77.4% for Q4 2025.

  • Quarterly results put Gross Margin at 77.4% for Q4 2025, up 198.0% from a year ago — trailing twelve months through Dec 2025 was 77.23% (up 329.0% YoY), and the annual figure for FY2025 was 77.23%, up 329.0%.
  • Gross Margin for Q4 2025 was 77.4% at NeuroPace, roughly flat from 77.39% in the prior quarter.
  • Over the last five years, Gross Margin for NPCE hit a ceiling of 77.4% in Q4 2025 and a floor of 68.83% in Q4 2022.
  • Median Gross Margin over the past 5 years was 73.53% (2021), compared with a mean of 74.01%.
  • Biggest five-year swings in Gross Margin: crashed -461bps in 2022 and later soared 637bps in 2023.
  • NeuroPace's Gross Margin stood at 73.44% in 2021, then fell by -6bps to 68.83% in 2022, then increased by 9bps to 75.2% in 2023, then increased by 0bps to 75.41% in 2024, then increased by 3bps to 77.4% in 2025.
  • The last three reported values for Gross Margin were 77.4% (Q4 2025), 77.39% (Q3 2025), and 77.09% (Q2 2025) per Business Quant data.